NanoVibronix today received publication of guidance from National Institute for Health and Care Excellence (NICE) in the U.K. for its UroShield device. England’s Department of Health and Social Care’s NICE issued guidance suggesting that UroShield has the potential to provide significant patient and healthcare system benefits to prevent catheter-associated urinary tract infections. Further U.K.-based research […]
nanovibronix
NanoVibronix wins reimbursement from CMS for PainShield device
NanoVibronix (NSDQ:NAOV) announced today that it won a unique reimbursement code from the Centers for Medicare and Medicaid for its PainShield surface acoustic wave portable ultrasonic therapeutic device. The Elmsford, N.Y.–based company develops medical devices based around its low-intensity SAW technology that allows the creation of low-frequency ultrasound waves that can be used in multiple medical […]
NanoVibronix touts trigeminal neuralgia PainShield study data
NanoVibronix (NSDQ:NAOV) yesterday released results from a study exploring the use of its PainShield device in treating patients with trigeminal neuralgia, touting improved pain relief and quality of life. The PainShield is a device designed to treat pain in nerves, muscles and joints through the delivery of localized ultrasound, the Elmsford, N.Y.-based company said. In the […]
7 medtech stories we missed this week: April 6, 2018
From CHF Solutions’s distribution deal to Guided Therapeutics’s licensing agreement, here are seven medtech stories we missed this week but throught were still worth mentioning. 1. CHF inks Spanish distribution deal CHF Solutions announced in an April 5 press release that it has signed a distribution agreement with Dimedix Surgical. The distribution agreement will allow […]
5 medtech stories we missed this week: Dec. 29, 2017
From NanoVibronix’s new Indian regulatory and distribution agreement to Guided Therapeutics’s Turkish distribution deal, here are five medtech stories we missed this week but thought were still worth mentioning. 1. NanoVibronix inks deal with Indian regulatory and distribution consultant NanoVibronix announced in a Dec. 20 press release that it has signed Morulaa HealthTech as its regulatory […]
5 medtech stories we missed this week: Dec. 22, 2017
From Hepa Wash’s new collaboration to Stimwave’s FDA clearance, here are five medtech stories we missed this week but thought were still worth mentioning. 1. Hepa Wash collaborates with GALS program Hepa Wash announced in a Dec. 7 press release that it has collaborated with the German Accelerator Life Sciences (GALS) program to expand its […]
NanoVibronix inks UK UroShield distro deal with IMS Ultrasound
NanoVibronix (NSDQ:NAOV) said today it inked a deal with the U.K.’s IMS Ultrasound to make it the exclusive U.K. distributor of its UroShield device, designed to prevent catheter-acquired urinary tract infections. The UroShield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also preventing bacterial colonization […]
NanoVibronix touts lowered UTIs in interim UroShield study results
NanoVibronix (NSDQ:NAOV) today released interim results from a trial of its UroShield ultrasound device designed to prevent bacteria and biofilms from forming on urinary catheters, touting a low rate of catheter-acquired urinary tract infections. The Uroshield device from the Elmsford, N.Y.-based company is designed to decrease pain and discomfort associated with urinary catheter use while also […]
NanoVibronix pulls down $5m from public offering
NanoVibronix (NSDQ:NAOV) said today that it pulled down more than $5 million from a public stock offering for its Surface Acoustic Wave antimicrobial platform. The Elmsford, N.Y.-based company said the $4.90-per-share offering, of 1.2 million shares of common stock with warrants to purchase an additional 918,366 shares, grossed $6 million, delivering $5.1 million in net proceeds. Those […]
NanoVibronix prices $6m offering
NanoVibronix (NSDQ:NVBXU) said this week it priced a $6 million public offering, with funds slated to cover expenses related to its listing on the NASDAQ Capital Market and to expand its sales teams. The Elmsford, N.Y.-based company is looking to float 1.2 million shares of its common stock with warrants to purchase an additional 918,366 shares […]
NanoVibronix touts bacterial reduction in interim UroShield study results
NanoVibronix (NSDQ:NVBXU) today released interim trial results from a study of its UroShield ultrasound device designed to prevent bacteria and biofilms from forming on urinary catheters, touting significant reductions in bacterial numbers. The study, which currently has 22 patients, compared patients treated with placebo devices to those with the UroShield. Upon initiation, each patient in the […]
